In the following video, Motley Fool health-care bureau chief Brenton Flynn discusses one criticism made by Eli Lilly (LLY +1.13%) CEO John Lechleiter of a problem facing big pharmaceutical companies in Europe: Drugs are too cheap. He specifically focuses on how differences in European health-care systems vs. those in the United States mean a lot of pressure to lower prices on pharmaceuticals in Europe, which is damaging to the industry.
Are Drug Prices Too Low?
By Brenton Flynn – Mar 7, 2013 at 6:00PM
NYSE: LLY
Eli Lilly
Market Cap
$848B
Today's Change
(1.13%) $10.09
Current Price
$906.62
Price as of November 4, 2025 at 3:58 PM ET